Early Access — free while we kick the tires
EdgarHawk

Sethna Meenal

Chief Financial Officer

Officer

Latest: CFO buying · May 2026

3 filings analyzed · 2 companies · Latest 2026-05-04
Validated high-conviction buyer — this insider’s opportunistic purchases fall in a cohort whose buys have historically preceded above-benchmark moves. How we measure this ↗

Companies

Company Buys Sells Direction
Option Care Health, Inc. OPCH 1 0 Net buying
LITTELFUSE INC /DE LFUS 0 6 Net selling

Activity

May 2026
2026-05-04 Option Care Health, Inc. OPCH Cluster
high
Buy
16,225 shares
$327,075
Significance 7/10

CFO Meenal's first open-market purchase in 3 years marks a regime shift from seller to buyer as stock falls sharply from 52-week highs.

Sethna Meenal, the CFO of Option Care Health, is purchasing shares for the first time on the open market in the past three years—a meaningful departure from a prior pattern of net selling. This purchase arrives as the stock trades roughly halfway down from its 52-week high, having declined substantially over the past quarter. The company itself remains profitable with solid revenue growth, suggesting that Meenal is buying weakness in a fundamentally sound business rather than catching a falling knife. This purchase is part of a broader wave, with three insiders buying within a two-week window—a pattern worth tracking. The shift from seller to buyer by the CFO, combined with deteriorating near-term price action, invites scrutiny into whether management sees value being created below current levels or if other factors are driving the activity.

May 2025
2025-05-14 LITTELFUSE INC /DE LFUS
high
Sell
4,000 shares
$877,075
Significance 6/10

CFO Sethna Meenal sells 4,000 shares (4.0K shares) for $877,075.00 at $219.27 avg, reducing LFUS stake by 14.2%

Meenal executed 2 separate sales totaling 4,000 shares for $877,075.00 on 2025-05-13, reducing her post-transaction holdings to 24,117 shares from 28,117 shares. The blended average price of $219.27 sits above the current price of $218.13 and near the 52-week high of $274.34, though still -20.5% from that high. Her cross-ticker track record shows a 100.00% well-timed rate on 6 prior sells with an average 90-day return of -6.2%, indicating her prior sales have consistently preceded stock declines. At LFUS specifically, she has 5 prior trades (3 of 3 prior measurable sells at 90-day mark showed negative returns of -6.9%, -7.1%, and -5.2%), establishing a pattern of selling before downturns at this ticker. The stock currently trades at a P/E of 56.51 with annual revenue declining -7.3% year-over-year, and LFUS has risen 37.0% over the last 30 days despite broader weakness. This sale, coming on the heels of two sales on 2025-05-05 (outcomes not yet measurable), continues an established pattern of divestment by the CFO.

2025-05-06 LITTELFUSE INC /DE LFUS
high
Sell
4,000 shares
$780,916
Significance 6/10

CFO Sethna sells 4,000 shares of LFUS at $195.23 avg ($780.9K); pattern repeats prior 4 same-ticker sales, all well-timed 90d-out.

Sethna Meenal, Executive VP and CFO, executed 2 separate sales totaling 4,000 shares for $780,915.65 on 2025-05-05 at a blended average price of $195.23. This represents a 14.2% reduction in his LFUS holdings (from 28.1K to 24.1K shares). The timing of this sale merits attention: his prior 4 open-market sales at LFUS, conducted on 2024-05-13 and 2024-05-14, all resulted in negative 90-day returns of -5.2% to -7.1%, placing them in the well-timed category (higher is better at 100.00% well-timed rate). The current sale occurs as LFUS trades at $190.58, down 30.5% from its 52-week high of $274.34, and the company faces headwinds: annual revenue growth is negative at -7.3%, and the P/E of 49.37 sits elevated relative to a contraction in top-line growth. Investors should monitor whether this sale follows the same 90-day pattern as his prior four transactions at this ticker, suggesting a consistent pattern of selling ahead of subsequent declines.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access